InvestorsHub Logo
Followers 105
Posts 16348
Boards Moderated 0
Alias Born 06/24/2014

Re: None

Monday, 02/26/2024 8:37:25 AM

Monday, February 26, 2024 8:37:25 AM

Post# of 80
LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LIXT News